Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: Effects of the i f current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome-RIVIERA trial study design and rationale

  1. Dominguez-Rodriguez, A. 11
  2. Fard, S.S. 1
  3. Abreu-Gonzalez, P. 2
  4. Bosa-Ojeda, F. 1
  5. Consuegra-Sanchez, L. 3
  6. Jiménez-Sosa, A. 1
  7. Grande, A.S. 1
  8. Kaski, J.C. 4
  1. 1 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    GRID grid.411220.4

  2. 2 Universidad de La Laguna
    info

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    GRID grid.10041.34

  3. 3 Hospital General Universitario Reina Sofía
    info

    Hospital General Universitario Reina Sofía

    Murcia, España

    GRID grid.411089.5

  4. 4 St George's, University of London
    info

    St George's, University of London

    Londres, Reino Unido

    GRID grid.264200.2

Journal:
Cardiovascular Drugs and Therapy

ISSN: 0920-3206

Year of publication: 2009

Volume: 23

Issue: 3

Pages: 243-247

Type: Article

Export: RIS
DOI: 10.1007/s10557-009-6164-9 PMID: 19229603 SCOPUS: 2-s2.0-67649090226 GOOGLE SCHOLAR
Data source: Scopus